Log in to save to my catalogue

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advan...

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9731716

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

About this item

Full title

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

Publisher

London: Nature Publishing Group UK

Journal title

Experimental and Molecular Medicine, 2021, 53(0), , pp.1-12

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The identification of predictive biomarkers or models is necessary for the selection of patients who might benefit the most from immunotherapy. Seven histological features (signet ring cell [SRC], fibrous stroma, myxoid stroma, tumor-infiltrating lymphocytes [TILs], necrosis, tertiary lymphoid follicles, and ulceration) detected in surgically resec...

Alternative Titles

Full title

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9731716

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9731716

Other Identifiers

ISSN

1226-3613

E-ISSN

2092-6413

DOI

10.1038/s12276-021-00559-1

How to access this item